| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 16 | 2025 | 1734 | 3.180 |
Why?
|
| Gene Editing | 7 | 2025 | 190 | 2.540 |
Why?
|
| Hepatocytes | 11 | 2025 | 225 | 2.300 |
Why?
|
| CRISPR-Cas Systems | 6 | 2024 | 258 | 2.140 |
Why?
|
| Chimera | 5 | 2018 | 87 | 2.070 |
Why?
|
| Hepatitis B virus | 6 | 2020 | 136 | 1.200 |
Why?
|
| Genetic Therapy | 5 | 2024 | 678 | 1.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2018 | 136 | 1.110 |
Why?
|
| Dependovirus | 4 | 2024 | 130 | 1.000 |
Why?
|
| Disease Models, Animal | 13 | 2024 | 4286 | 0.980 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2023 | 4 | 0.870 |
Why?
|
| Heterografts | 5 | 2020 | 179 | 0.860 |
Why?
|
| Copper | 6 | 2005 | 62 | 0.810 |
Why?
|
| Lysine | 1 | 2023 | 199 | 0.800 |
Why?
|
| Tyrosinemias | 2 | 2024 | 7 | 0.780 |
Why?
|
| Argininosuccinate Lyase | 2 | 2018 | 59 | 0.750 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2018 | 52 | 0.730 |
Why?
|
| Mice | 28 | 2025 | 17538 | 0.720 |
Why?
|
| Animals | 36 | 2025 | 33791 | 0.680 |
Why?
|
| Hydrolases | 4 | 2025 | 52 | 0.670 |
Why?
|
| Xenobiotics | 1 | 2018 | 27 | 0.620 |
Why?
|
| Inactivation, Metabolic | 1 | 2018 | 32 | 0.620 |
Why?
|
| Cation Transport Proteins | 4 | 2005 | 96 | 0.600 |
Why?
|
| Adenosine Triphosphatases | 5 | 2005 | 208 | 0.590 |
Why?
|
| Atazanavir Sulfate | 1 | 2017 | 5 | 0.580 |
Why?
|
| Quinazolines | 1 | 2017 | 176 | 0.530 |
Why?
|
| Mice, Knockout | 8 | 2024 | 3719 | 0.510 |
Why?
|
| Receptors, LDL | 2 | 2017 | 88 | 0.510 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 184 | 0.500 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2015 | 84 | 0.460 |
Why?
|
| Hepatitis B | 2 | 2020 | 159 | 0.460 |
Why?
|
| Antiviral Agents | 2 | 2018 | 747 | 0.450 |
Why?
|
| Monocytes | 1 | 2016 | 345 | 0.450 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 320 | 0.450 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 2 | 2022 | 10 | 0.410 |
Why?
|
| Drug Discovery | 1 | 2013 | 170 | 0.390 |
Why?
|
| Transplantation Chimera | 2 | 2015 | 39 | 0.380 |
Why?
|
| Hepatitis B, Chronic | 3 | 2018 | 82 | 0.380 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 253 | 0.360 |
Why?
|
| Liver Neoplasms | 4 | 2024 | 1310 | 0.340 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1691 | 0.330 |
Why?
|
| Mice, Inbred Strains | 4 | 2017 | 311 | 0.320 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 764 | 0.300 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2020 | 65 | 0.290 |
Why?
|
| Oxidoreductases | 2 | 2018 | 92 | 0.280 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2023 | 937 | 0.280 |
Why?
|
| Depressive Disorder, Major | 2 | 2022 | 398 | 0.280 |
Why?
|
| Immune Tolerance | 1 | 2007 | 145 | 0.280 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 571 | 0.270 |
Why?
|
| Hep G2 Cells | 4 | 2020 | 88 | 0.260 |
Why?
|
| Hepatitis C | 1 | 2010 | 364 | 0.260 |
Why?
|
| Humans | 32 | 2025 | 123070 | 0.260 |
Why?
|
| Carrier Proteins | 2 | 2001 | 1017 | 0.260 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 289 | 0.240 |
Why?
|
| Enterococcus | 2 | 2001 | 32 | 0.240 |
Why?
|
| Menkes Kinky Hair Syndrome | 2 | 2001 | 5 | 0.230 |
Why?
|
| Microsomes, Liver | 2 | 2021 | 85 | 0.220 |
Why?
|
| Simplexvirus | 1 | 2003 | 105 | 0.200 |
Why?
|
| Hepatitis | 1 | 2003 | 59 | 0.200 |
Why?
|
| Models, Animal | 2 | 2018 | 464 | 0.200 |
Why?
|
| Molybdenum | 1 | 2001 | 16 | 0.200 |
Why?
|
| Nitrobenzoates | 2 | 2024 | 6 | 0.200 |
Why?
|
| Cyclohexanones | 2 | 2024 | 19 | 0.190 |
Why?
|
| Gene Targeting | 2 | 2025 | 178 | 0.190 |
Why?
|
| Hepatoblastoma | 1 | 2024 | 178 | 0.190 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2001 | 33 | 0.190 |
Why?
|
| Plasmids | 2 | 2018 | 511 | 0.180 |
Why?
|
| Liver Regeneration | 1 | 2000 | 38 | 0.180 |
Why?
|
| Transfection | 2 | 2020 | 1068 | 0.180 |
Why?
|
| Carbohydrates | 1 | 2020 | 33 | 0.180 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2020 | 38 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4352 | 0.170 |
Why?
|
| Blood Vessels | 1 | 2020 | 104 | 0.170 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 369 | 0.170 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2000 | 75 | 0.170 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 122 | 0.170 |
Why?
|
| Neovascularization, Pathologic | 2 | 2018 | 240 | 0.170 |
Why?
|
| Tissue Scaffolds | 1 | 2020 | 74 | 0.170 |
Why?
|
| Hepatectomy | 1 | 2000 | 109 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2020 | 809 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2020 | 2307 | 0.160 |
Why?
|
| Oocytes | 1 | 2001 | 290 | 0.160 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 197 | 0.160 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 207 | 0.160 |
Why?
|
| Copper-transporting ATPases | 3 | 2005 | 25 | 0.150 |
Why?
|
| Tissue Engineering | 1 | 2020 | 176 | 0.150 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 389 | 0.150 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2018 | 47 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 249 | 0.150 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2017 | 61 | 0.150 |
Why?
|
| Phenotype | 2 | 2018 | 4221 | 0.150 |
Why?
|
| Cytochromes | 1 | 2017 | 7 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 216 | 0.150 |
Why?
|
| Fetal Stem Cells | 1 | 2017 | 5 | 0.140 |
Why?
|
| Virion | 1 | 2018 | 149 | 0.140 |
Why?
|
| Recombinational DNA Repair | 1 | 2017 | 19 | 0.140 |
Why?
|
| HIV Protease Inhibitors | 1 | 2017 | 53 | 0.140 |
Why?
|
| Liver Transplantation | 2 | 2015 | 1015 | 0.130 |
Why?
|
| HIV-1 | 1 | 2020 | 463 | 0.130 |
Why?
|
| Amniotic Fluid | 1 | 2017 | 151 | 0.130 |
Why?
|
| Mutagenesis | 1 | 2017 | 347 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 373 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 130 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 74 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2015 | 47 | 0.120 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 357 | 0.120 |
Why?
|
| Viremia | 1 | 2015 | 126 | 0.120 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 190 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2015 | 52 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2018 | 528 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 477 | 0.120 |
Why?
|
| Lipoproteins | 1 | 2015 | 177 | 0.110 |
Why?
|
| Genome | 1 | 2017 | 473 | 0.110 |
Why?
|
| RNA Interference | 1 | 2015 | 496 | 0.110 |
Why?
|
| Exons | 1 | 2016 | 794 | 0.110 |
Why?
|
| Tuberculosis | 1 | 2020 | 512 | 0.110 |
Why?
|
| Cell Line | 2 | 2016 | 2771 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2007 | 394 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 66 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2018 | 662 | 0.110 |
Why?
|
| Duloxetine Hydrochloride | 2 | 2022 | 11 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2017 | 618 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 2055 | 0.090 |
Why?
|
| Rats | 3 | 2020 | 3654 | 0.090 |
Why?
|
| Genotype | 1 | 2017 | 2533 | 0.090 |
Why?
|
| Serotonin | 2 | 2022 | 232 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2003 | 3016 | 0.090 |
Why?
|
| Hypertension | 1 | 2018 | 1286 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 672 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 172 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2015 | 1475 | 0.080 |
Why?
|
| Female | 7 | 2018 | 65529 | 0.080 |
Why?
|
| Stem Cells | 1 | 2013 | 701 | 0.080 |
Why?
|
| Hepacivirus | 1 | 2010 | 241 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1661 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1909 | 0.070 |
Why?
|
| HIV Infections | 1 | 2020 | 1855 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2020 | 570 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 1872 | 0.070 |
Why?
|
| Mutation | 2 | 2017 | 5765 | 0.070 |
Why?
|
| Rats, Inbred LEC | 1 | 2005 | 1 | 0.060 |
Why?
|
| Electrophoresis | 1 | 2005 | 47 | 0.060 |
Why?
|
| Genes, Essential | 1 | 2025 | 40 | 0.060 |
Why?
|
| 4-Hydroxyphenylpyruvate Dioxygenase | 1 | 2024 | 1 | 0.060 |
Why?
|
| Electroporation | 1 | 2024 | 33 | 0.060 |
Why?
|
| Male | 6 | 2018 | 60080 | 0.060 |
Why?
|
| Child | 4 | 2018 | 24226 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 887 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 56 | 0.060 |
Why?
|
| Organ Size | 1 | 2005 | 412 | 0.060 |
Why?
|
| Rats, Wistar | 1 | 2005 | 360 | 0.060 |
Why?
|
| Transgenes | 1 | 2025 | 334 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 74 | 0.050 |
Why?
|
| Carcinogens | 1 | 2023 | 153 | 0.050 |
Why?
|
| Vincristine | 1 | 2024 | 196 | 0.050 |
Why?
|
| Acyclovir | 1 | 2003 | 45 | 0.050 |
Why?
|
| Central Nervous System Agents | 1 | 2022 | 15 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 32 | 0.050 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2024 | 157 | 0.050 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2022 | 48 | 0.050 |
Why?
|
| Kinetics | 2 | 2001 | 1313 | 0.050 |
Why?
|
| Colectomy | 1 | 2003 | 75 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2003 | 57 | 0.050 |
Why?
|
| Propranolol | 1 | 2022 | 128 | 0.050 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2003 | 54 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3042 | 0.050 |
Why?
|
| Silver | 1 | 2001 | 22 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 75 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2005 | 485 | 0.050 |
Why?
|
| Artificial Gene Fusion | 1 | 2001 | 11 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 2395 | 0.050 |
Why?
|
| Oxygen | 1 | 2005 | 547 | 0.050 |
Why?
|
| Quinolines | 1 | 2001 | 96 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2001 | 122 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 239 | 0.050 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 2000 | 5 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2023 | 328 | 0.040 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2020 | 15 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 157 | 0.040 |
Why?
|
| Marmota | 1 | 2020 | 2 | 0.040 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2020 | 4 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2000 | 71 | 0.040 |
Why?
|
| Colitis, Ulcerative | 1 | 2003 | 207 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2020 | 175 | 0.040 |
Why?
|
| Hydrogels | 1 | 2020 | 78 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2020 | 167 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 330 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 771 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 348 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 68 | 0.040 |
Why?
|
| Reoperation | 1 | 2003 | 819 | 0.040 |
Why?
|
| Perfusion | 1 | 2020 | 198 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 307 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2001 | 460 | 0.040 |
Why?
|
| Cell Division | 1 | 2000 | 780 | 0.040 |
Why?
|
| Rabbits | 1 | 2020 | 709 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2020 | 492 | 0.040 |
Why?
|
| Equipment Design | 1 | 2020 | 601 | 0.040 |
Why?
|
| Coinfection | 1 | 2020 | 171 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2001 | 1070 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1118 | 0.040 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2018 | 77 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 741 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2001 | 1608 | 0.040 |
Why?
|
| Nanog Homeobox Protein | 1 | 2017 | 27 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 1214 | 0.040 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2017 | 42 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 285 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2017 | 92 | 0.030 |
Why?
|
| Metabolomics | 1 | 2020 | 408 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2017 | 121 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 160 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2017 | 131 | 0.030 |
Why?
|
| Virus Replication | 1 | 2020 | 603 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 1688 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 147 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2001 | 877 | 0.030 |
Why?
|
| Hepatitis B e Antigens | 1 | 2015 | 13 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1742 | 0.030 |
Why?
|
| DNA, Circular | 1 | 2015 | 18 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2017 | 115 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 439 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 514 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1443 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2015 | 462 | 0.030 |
Why?
|
| Time Factors | 1 | 2005 | 6222 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 229 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2015 | 479 | 0.030 |
Why?
|
| Homeostasis | 1 | 1998 | 683 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 514 | 0.030 |
Why?
|
| Viral Load | 1 | 2015 | 381 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 664 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2826 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 1061 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2015 | 540 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 795 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 1325 | 0.030 |
Why?
|
| Base Sequence | 1 | 2017 | 3092 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 861 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 861 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2015 | 940 | 0.020 |
Why?
|
| Computational Biology | 1 | 2015 | 796 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1997 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3293 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 614 | 0.020 |
Why?
|
| Neoplasms | 1 | 2020 | 2758 | 0.020 |
Why?
|
| United States | 1 | 2020 | 10651 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 7159 | 0.010 |
Why?
|
| Adult | 1 | 2003 | 29011 | 0.010 |
Why?
|
| Surface Plasmon Resonance | 1 | 2001 | 45 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2001 | 167 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 19096 | 0.010 |
Why?
|